Eli Lilly and Company has revealed a substantial investment in India of up to $1 billion over the next few years to build new contract manufacturing facilities and a new advanced manufacturing and quality hub in Hyderabad. The US pharma company...
Indian pharmaceutical companies are entering global partnerships to produce a generic version of Gilead Sciences’ HIV prevention drug, with public health advocates urging that its launch be prioritized in India to improve patient access
Wockhardt shares surged 7.45% to 1,435 following the publication of positive Phase 3 clinical trial results for its novel antibiotic Miqnaf (nafithromycin)
The results of a statewide review of 3.9 lakh lipid profile tests performed in the previous year have been made public by Metropolis Healthcare. According to the study, there has been a worrying change in the cardiovascular landscape of India
Global pharmaceutical giant Lupin Limited disclosed that its wholly owned subsidiary, Nanomi B.V., has executed a definitive agreement to acquire VISUfarma B.V., a specialty eye health company backed by GHO Capital Partners...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently held a crucial meeting with the NICDC Logistics Data Services Limited (NLDSL) to launch Logistics e-Marketplace (LeMP) and a new under-development portal search engine regard
FUJIFILM India, a worldwide leader in healthcare technology, has opened an advanced digital radiology X-Ray facility at the Community Health Centre (CHC) in Dholera. This initiative, part of the company's CSR initiative, is intended to address...
Pinkathon, India's largest women's run, and Zydus Lifesciences Ltd., a global healthcare organization driven by innovation, announced the 10th Mumbai Pinkathon, which would take place at MMRDA Grounds, BKC, on December 21, 2025. Zydus has partnered
In a significant move to combat antimicrobial resistance, the Union Health Ministry has banned the import, manufacture, and sale of 34 antimicrobials and their formulations for use in animals
Alembic Pharmaceuticals Limited has announced today that it has obtained final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) pertaining to Paroxetine Extended-Release Tablets USP...
.jpg)
.jpg)
, CDSCO.jpg)